CD8A and neoplasm: It was reported that PSMB8.AS1 is enriched in immune response processes, which increased CD8 T-cell tumor infiltration and trans-regulation of genes in immune-related pathways, suggesting that an epigenetically mediated immune response is a predictor of recurrence and, possibly, treatment response for high-grade serous (HGS) EOC [34].